MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹8,300 Cr | ₹196 Cr | ₹163 Cr | ₹868 Cr | ₹235 Cr |
What is the latest Total Debt ratio of MANKIND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹8,300 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹868 Cr |
| Mar2021 | ₹235 Cr |
How is Total Debt of MANKIND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,300 Cr | 4,134.07 | |
| Mar2024 | ₹196 Cr | 20.54 | |
| Mar2023 | ₹163 Cr | -81.26 | |
| Mar2022 | ₹868 Cr | 270.12 | |
| Mar2021 | ₹235 Cr | - | |
Compare Total Debt of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹82,033.7 Cr | -5.5% | -2% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -5.5% |
-2% |
-11.1% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses